Microarrays - Oxford Gene Technology
(Isis - 546)
Founded in 1995 by the pioneer of Southern Blotting, Professor Sir Edwin Southern, Oxford Gene Technology Limited (OGT) offers a comprehensive custom microarray consultancy service, from experimental design through all stages to data analysis and interpretation. It has a strong proven track record in providing custom microarray service in a range of applications including Gene Expression (GE), Comparative Genome Hybridisation (CGH) and Chromatin Immunoprecipitation (ChIP).
Isis was involved in the initial patent applications and the transfer of the intellectual property to the company.
Some of the royalty income from licensing microarray technology is used to fund charities supporting scientific advancement – The Kirkhouse Trust and the Edina Trust.
OGT's management team brings a unique combination of world-recognised science, combined with a strong track record in licensing intellectual property, product development and commercialisation of technology.
The key focus areas of OGT are:
- Cytogenetics products and services: For high-resolution detection of chromosomal abnormalities. CytoSure™ arrays are the first oligonucleotide microarrays designed exclusively for the cytogenetics research community to achieve accurate, high-resolution analysis of chromosome copy number and structural changes.
- Digital microarrays/Single cell analysis: OGT's innovative, patent-protected technology development programme is aimed at analysing genomic events at the single cell level for major applications such as stem cell and cancer biology.
- Licensing: OGT operates an open licensing policy which has successfully provided access for a number of companies to OGT's fundamental intellectual property, particularly in the area of microarrays.
Lead Researcher: Professor Sir Edwin Southern
University Department: Sir William Dunn School of Pathology
Date of disclosure to Isis: 1995
Isis News